(in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $729431.9 | $491438.6 | $1123435.1 | $841459.5 |
Short term investments | $416536.1 | |||
Net receivables | $173127.3 | $189801.4 | ||
Inventory | ||||
Total current assets | $729431.9 | $664565.9 | $1123435.1 | $1031260.9 |
Long term investments | $2866937.5 | $2966505.1 | $2746081.3 | $2658725.6 |
Property, plant & equipment | $48374.9 | $47616.2 | $46791.2 | $44045 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $12097903 | $11747339.9 | $11955285.1 | $11307838.3 |
Current liabilities | ||||
Accounts payable | $8100419.1 | $8024243.8 | $8209141.6 | $7705860.9 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $8100419.1 | $8024243.8 | $8209141.6 | $7705860.9 |
Long term debt | $1994403 | $1869655.6 | $1997781.6 | $1918823.4 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $10809317.6 | $10514494.6 | $10770065 | $10169078.1 |
Shareholders' equity | ||||
Retained earnings | $617262.3 | |||
Other shareholder equity | $1279062.7 | $1223557.1 | $1176467.1 | $1130270.8 |
Total shareholder equity | $1285207.3 | $1229700 | $1182606.6 | $1136406.1 |
(in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
---|---|---|---|---|
Current assets | ||||
Cash | $1123435.1 | $242889.44 | $208284.32 | $371184.89 |
Short term investments | $416536.1 | $468856.8 | $464629.2 | $281617.7 |
Net receivables | ||||
Inventory | $87.28 | |||
Total current assets | $1123435.1 | $1194171.59 | $1531877.99 | $1050272.06 |
Long term investments | $2746081.3 | $1860558.7 | $1207798.54 | $1447719.15 |
Property, plant & equipment | $46791.2 | $43296.93 | $43943.39 | $41298.82 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $11955285.1 | $10103253.27 | $9278718.06 | $8140459.68 |
Current liabilities | ||||
Accounts payable | $8209141.6 | $7076234.21 | $6421572.09 | $5507459.35 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $8209141.6 | $7185543.12 | $6492592.84 | $5592931.66 |
Long term debt | $1997781.6 | $1522487.18 | $1551801.66 | $1612498.29 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $10770065 | $9065578.8 | $8414178.21 | $7461587.34 |
Shareholders' equity | ||||
Retained earnings | $617262.3 | $481964.85 | $418305.14 | $390445.01 |
Other shareholder equity | $1176467.1 | $35124.32 | $27757.21 | $22616.36 |
Total shareholder equity | $1182606.6 | $1035937 | $863404.29 | $678026.19 |
(in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $145616.4 | $127376.1 | $128542.8 | $119325.1 |
Cost of revenue | ||||
Gross Profit | $145616.4 | $127376.1 | $128542.8 | $119325.1 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $23820.8 | $23946 | $21270.3 | $21393.8 |
Total operating expenses | $69889 | $68547.9 | $69515.9 | $66311.2 |
Operating income | $75727.4 | $58828.2 | $59026.9 | $53013.9 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $19474.9 | $14936 | $14686.9 | $13283.2 |
Interest expense | ||||
Net income | ||||
Net income | $56123.3 | $43805.9 | $44177.3 | $39569.5 |
Income (for common shares) | $56123.3 | $43805.9 | $44177.3 | $39569.5 |
(in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $437536.9 | $264272.63 | $199445.13 | $217672.78 |
Cost of revenue | ||||
Gross Profit | $437536.9 | $264272.63 | $199445.13 | $217672.78 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $84140.6 | $119404.67 | $104561.48 | $103083.88 |
Total operating expenses | $248242.3 | $191748.75 | $180657.58 | $167201.87 |
Operating income | $189294.6 | $72523.88 | $18787.55 | $50470.91 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $47651.1 | $24976.9 | ||
Interest expense | ||||
Net income | ||||
Net income | $141192.9 | $71954.96 | $18531.14 | $50385.89 |
Income (for common shares) | $141192.9 | $71954.96 | $18531.14 | $50385.89 |
(in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
---|---|---|---|---|
Net income | $56123.3 | $43805.9 | $44177.3 | $39569.5 |
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | ||||
Effect of exchange rate | ||||
Change in cash and equivalents |
(in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
---|---|---|---|---|
Net income | $141192.9 | $71954.96 | $18531.14 | $50385.89 |
Operating activities | ||||
Depreciation | $10489.9 | $6998.7 | $5707.03 | $5298.49 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | -$944742.3 | -$528333.32 | -$609956.38 | -$579629.23 |
Investing activities | ||||
Capital expenditures | -$14089.7 | -$9384.36 | -$11042.69 | -$8803.66 |
Investments | -$258303.8 | -$532699.29 | -$85819.36 | -$178658.51 |
Total cash flows from investing | -$272321 | -$541948.21 | -$96588.63 | -$186914.93 |
Financing activities | ||||
Dividends paid | -$3318.57 | -$269.49 | ||
Sale and purchase of stock | ||||
Net borrowings | $475294.5 | -$29314.48 | -$60696.63 | $54827.37 |
Total cash flows from financing | $1705056.1 | $727455.45 | $1002764.07 | $1007307.67 |
Effect of exchange rate | $1198.7 | -$928.14 | $1735.6 | $171.44 |
Change in cash and equivalents | $489191.5 | -$343754.22 | $297954.66 | $240934.95 |
Health Care Roundup: Market Talk
The Wall Street Journal
16 May 2024
|
Financial Services Roundup: Market Talk
The Wall Street Journal
24 Apr 2024
|
Accused of defaulting on loans, Tommy’s Boats sues boatmaker
WOOD via Yahoo Finance
15 Apr 2024
|
Paytm Wins Payments Approval It Needs to Stay in Business
Bloomberg via Yahoo Finance
15 Mar 2024
|
Stock Market Today: Nifty and Sensex look to a subdued open on Friday
The Forex Market
23 Feb 2024
|
Paytm crisis: No forex violations found by probe agency yet, says report
MSN News
19 Feb 2024
|
Jefferies stops coverage of Paytm stock. Here's why
MSN News
19 Feb 2024
|
Explained: Why Paytm shares hit 5% upper circuit today
MSN News
19 Feb 2024
|
'Till news settles down': Jefferies stops Paytm coverage, first foreign brokerage to do so
MSN News
19 Feb 2024
|
2 Nifty 50 Stocks With HIGHEST FII Holdings
Investing.com
18 Feb 2024
|
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | $520.86B |
---|---|
EBITDA | N/A |
EBIT | $0.00 |
Net Income | $183.68B |
Revenue Q/Q | 37.29% |
Revenue Y/Y | 57.46% |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | 1.56% |
ROE | 15.20% |
Debt/Equity | 9.11 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.09 |
Quick ratio | N/A |